During the course of the projection period, growth in the market is anticipated as a result of the 340b program’s potential to increase demand for hospital pharmacies. For instance, studies published in the online database Science Direct in November 2021 showed that 340B hospitals in the United States provided drug access services more frequently and on average in higher volumes than non-340B hospitals. These programs are known to raise the level of care and increase access for patients with limited financial resources.
Global Pemetrexed Market size was valued at US$ 2,287.2 Million in 2022 and is expected to witness a CAGR of 2.2% over the forecast period (2022 – 2030).
Market Leaders in the Pemetrexed Industry:
1) Eli Lilly and Company: A pharmaceutical company called Eli Lilly has specialties in immunology, oncology, neuroscience, and endocrinology. Verzenio, Mounjaro, Jardiance, Trulicity, Humalog, and Humulin are among Lilly's most important cancer, diabetes, and immunology drugs. Taltz and Olumiant are among its significant cancer and diabetes products. established in 1876. Headquartered in the US city of Indianapolis, Indiana. Lilly and Entos Pharmaceuticals have signed a research and collaboration agreement to support the development of novel treatments for a variety of neurologic conditions.
2) Stada Arzneimittel AG: Manufacturing both specialised and generic medications is STADA Arzneimittel AG. Generic drug goods make up the great majority of the company's sales, followed by branded products. It works in three divisions: Consumer Healthcare, Specialty, and Generics. German headquarters in Bad Vilbel. Built in 1895. Adalvo and STADA recently signed licencing agreements for five more compounds, extending their strategic alliance. STADA will have commercial rights to the compounds in Europe starting in 2023 thanks to the agreements.
3) Eagle Pharmaceuticals, Inc: Eagle Pharmaceuticals Inc. is a company that specialises in drugs. The company manufactures and sells injectable medications for use in oncology, critical care, and orphan diseases. The four authorised products that make up the company's product line are Ryanodex, Belrapzo, Argatroban, and Bendeka. The headquarters are located in New Jersey, USA. 2007-era business. Eagle Pharmaceuticals and Enalare Therapeutics have been given a second BARDA award for up to $50 million to further the development of an intramuscular formulation of ENA-001.
4) Fresenius Kabi USA: German Bad Homburg serves as the headquarters. created in 1966. A healthcare holding corporation with four components, Fresenius SE is situated in Germany. Almost half of the firm's consolidated revenue is derived from the dialysis service provider and equipment maker Fresenius Medical Care, in which the corporation has a sizable share. In 2021, Fresenius Kabi and Health Care Logistics®, Inc. (HCL) established a partnership that aims to increase hospital drug replenishment efficiency and boost patient safety during the medication-use process.
5) Teva Pharmaceuticals USA, Inc: Based in Israel, Teva Pharmaceutical Industries Ltd. develops, produces, markets, and distributes generic drugs, novel pharmaceuticals, and biopharmaceuticals along with its subsidiaries and affiliated businesses. American headquarters in Parsippany-Troy Hills, New Jersey. Built in 1901.
6) Biocon, Pfizer Inc.: One of the biggest pharmaceutical companies in the world, Pfizer has yearly sales of around $50 billion (excluding COVID-19 product sales). The company used to sell a wide variety of chemicals and healthcare items, but today the majority of its sales come from prescription medications and vaccinations. American headquarters in New York, New York. Built in 1624.
Definition: A medication used alone or in combination with other medications to treat specific forms of malignant pleural mesothelioma and non-small cell lung cancer. It is also being investigated for the treatment of further cancers.
